Aehr Test Systems Beats Q1 Estimates, Reiterates Guidance: Here Are The Details

Aehr Test Systems AEHR shares are trading lower after the company reported first-quarter financial results.

What To Know: Aehr reported quarterly earnings of 18 cents per share which beat the analyst consensus estimate of 16 cents, a 260% increase over earnings of five cents per share from the same period last year. The company reported quarterly sales of $20.62 million which beat the analyst consensus estimate of $19.23 million, a 93.27% increase over sales of $10.67 million the same period last year.

Total cash, cash equivalents, and short-term investments were $51.0 million as of Aug. 31, up from $47.9 million at May 31.

The company reiterated full-year 2024 previously provided guidance for total revenue to be at least $100 million, versus the $102.93 million estimate.

"We finished the first quarter with solid revenue and non-GAAP net income, the strongest first quarter in our history, which has historically been our seasonally softest quarter. We are off to a very good start to our fiscal year and are reaffirming our expectation to grow fiscal full year revenue by at least 50% and profit by over 90% year over year," said Gayn Erickson, president and CEO of Aehr Test Systems.

Related Link: Why Insulet Stock Traded Lower

AEHR Price Action: Shares of AEHR were down 11.35% at $39.19 in the after-hours session at the time of publication, according to Benzinga Pro.

Photo: Republica from Pixabay

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsSmall CapAfter-Hours CenterMoverssemiconductorwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!